Synonyms: DNIB0600A | RG-7599 | RG7599
Compound class:
Antibody
Comment: Lifastuzumab vedotin is an antibody drug conjugate containing an anti-SLC34A2 (sodium phosphate 2 transporter) monoclonal antibody linked to the toxin monomethyl auristatin E (MMAE, aka vedotin; PubChem CID 11542188).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. Peptide sequence match identifies US8535675 as the covering patent [2], and also identifies the target antigen denoted as TAT211 in this patent as the sodium phosphate transporter. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
9835 | lifastuzumab vedotin |
Synonyms ![]() |
DNIB0600A | RG-7599 | RG7599 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 478 |
Other databases | |
GtoPdb PubChem SID | 252166615 |
Search PubMed clinical trials | lifastuzumab vedotin |
Search PubMed titles | lifastuzumab vedotin |
Search PubMed titles/abstracts | lifastuzumab vedotin |
Wikipedia | Lifastuzumab vedotin |